Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bexxar Consolidation in DLBCL
NCT00022932Phase 2Unknown
- Sponsor
- Corixa Corporation
- Start
- Jan 2000
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of tositumomab in diffuse large B-cell lymphoma (DLBCL), sponsored by Corixa Corporation. Status: unknown.
02
Drugs
tositumomab
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT00022932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00022932.